Optimising antimicrobial therapy in diabetic foot infections

Area of Science:

• Infectious Diseases
• Diabetology
• Podiatry

Background:

• Foot infections are a severe complication of diabetes mellitus, frequently leading to lower extremity amputations.
• Infections often arise from foot ulcerations, typically following trauma to a neuropathic foot in diabetic patients.
• Infection severity (mild, moderate, severe) dictates therapeutic strategies.

Purpose of the Study:

• To outline the classification and management of diabetic foot infections.
• To discuss appropriate antibacterial therapy selection based on infection characteristics and causative pathogens.
• To highlight the challenges in managing diabetic foot osteomyelitis and the role of surgical intervention.

Main Methods:

• Review of current literature and clinical guidelines for diabetic foot infections.
• Analysis of causative pathogens, differentiating between Gram-positive and polymicrobial infections.
• Evaluation of treatment approaches including antibiotic selection, surgical debridement, and duration of therapy.

Main Results:

• Mild to moderate infections are typically Gram-positive and treatable with narrow-spectrum antibiotics and debridement.
• Severe infections are often polymicrobial, necessitating broad-spectrum antibiotics, hospitalization, and comprehensive interventions.
• No single antibacterial regimen has demonstrated superiority; treatment should be guided by culture and sensitivity results.

Conclusions:

• Effective management of diabetic foot infections requires accurate diagnosis, appropriate antimicrobial selection, and timely surgical intervention.
• Addressing the increasing incidence of methicillin-resistant Staphylococcus aureus is critical.
• Duration of antibiotic therapy varies significantly, from weeks for soft tissue infections to over six weeks for osteomyelitis.